BG

Bellevue Group Portfolio holdings

AUM $4.81B
1-Year Est. Return 29.28%
This Quarter Est. Return
1 Year Est. Return
+29.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.54B
AUM Growth
+$74.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
155
New
Increased
Reduced
Closed

Top Buys

1
+$39.2M
2
+$38.3M
3
+$36.5M
4
TMO icon
Thermo Fisher Scientific
TMO
+$20M
5
EWTX icon
Edgewise Therapeutics
EWTX
+$17.7M

Top Sells

1
+$35.5M
2
+$29.9M
3
+$25.6M
4
BSX icon
Boston Scientific
BSX
+$20M
5
COR icon
Cencora
COR
+$19M

Sector Composition

1 Healthcare 99.88%
2 Technology 0.01%
3 Consumer Discretionary 0.01%
4 Communication Services 0.01%
5 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCS icon
126
Oculis Holding
OCS
$1.46B
$188K ﹤0.01%
9,700
-4,400
PTCT icon
127
PTC Therapeutics
PTCT
$5.82B
$186K ﹤0.01%
3,800
GRMN icon
128
Garmin
GRMN
$40.7B
$177K ﹤0.01%
850
KRYS icon
129
Krystal Biotech
KRYS
$8.27B
$172K ﹤0.01%
1,250
-1,400
BIDU icon
130
Baidu
BIDU
$51.4B
$172K ﹤0.01%
2,000
ORCL icon
131
Oracle
ORCL
$549B
$143K ﹤0.01%
654
MLTX icon
132
MoonLake Immunotherapeutics
MLTX
$1.19B
$142K ﹤0.01%
3,000
CYTK icon
133
Cytokinetics
CYTK
$7.65B
$124K ﹤0.01%
3,741
NVDA icon
134
NVIDIA
NVDA
$4.53T
$119K ﹤0.01%
751
ZTS icon
135
Zoetis
ZTS
$54.9B
$102K ﹤0.01%
657
-2,457
MSFT icon
136
Microsoft
MSFT
$3.42T
$101K ﹤0.01%
203
A icon
137
Agilent Technologies
A
$39.6B
$95.1K ﹤0.01%
806
QCOM icon
138
Qualcomm
QCOM
$171B
$71.2K ﹤0.01%
447
BIIB icon
139
Biogen
BIIB
$24.1B
$50.5K ﹤0.01%
402
MTD icon
140
Mettler-Toledo International
MTD
$29.8B
$49.3K ﹤0.01%
42
RXRX icon
141
Recursion Pharmaceuticals
RXRX
$2.43B
$27.9K ﹤0.01%
5,514
-189,538
TEM
142
Tempus AI
TEM
$12.5B
$15.1K ﹤0.01%
237
ALT icon
143
Altimmune
ALT
$442M
– –
-1,056,793
BIO icon
144
Bio-Rad Laboratories Class A
BIO
$8.46B
– –
-21,476
BRKR icon
145
Bruker
BRKR
$7.35B
– –
-335,288
CSTL icon
146
Castle Biosciences
CSTL
$1.17B
– –
-301,103
ESPR icon
147
Esperion Therapeutics
ESPR
$721M
– –
-9,694,064
EVH icon
148
Evolent Health
EVH
$421M
– –
-614,337
PCVX icon
149
Vaxcyte
PCVX
$6.1B
– –
-11,290
RDY icon
150
Dr. Reddy's Laboratories
RDY
$10.8B
– –
-91,916
3 4 5
6
7